Literature DB >> 15118371

CCR4 Expression by atypical T cells in systemic pilotropic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid.

Taku Fujimura1, Setsuya Aiba, Yumiko Yoshino, Shigeru Kuroki, Yutaka Kimura, Katsuko Kikuchi, Takahide Kunii, Jun Matsunaga, Kouji Matsushima, Hachiro Tagami.   

Abstract

We describe an 88-year-old Japanese patient with pilotropic T cell lymphoma involving the peripheral blood as well as lymph nodes. This patient presented with multiple red follicular papules, confluent, infiltrated erythematous plaques and nodules. Moreover, he was conspicuous for the presence of total alopecia of the scalp and eyebrows. Histopathologically, the lesional skin showed dense follicular and perifollicular infiltrates of atypical lymphocytes. The flow cytometry disclosed the presence of weakly CD4+ CCR4+ cell populations that would not be detected in the peripheral blood from healthy controls. The patient responded well to topical PUVA and systemic etretinate (retinoid-PUVA) and intravenous IFN-gamma. Parallel with the decrease in atypical cells in the peripheral blood, the percentage of weakly CD4+ CCR4+ T cells declined. However, about 1 week after we discontinued this treatment because of the side effects, the lymph node swelling became prominent, and, 4 weeks later, the patient died before restarting any specific chemotherapy. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118371     DOI: 10.1159/000077303

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Pseudolymphomatous folliculitis on the nose.

Authors:  Aya Kakizaki; Taku Fujimura; Ikuko Numata; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-01-30

2.  Dermoscopy findings of pseudolymphomatous folliculitis.

Authors:  Taku Fujimura; Takanori Hidaka; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.